Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Hyperlipidaemia”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Not applicableLooking for participantsNCT06752772
What this trial is testing

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

Who this might be right for
Elevated Blood PressureHypertensionOverweight/Obesity+3 more
Alexandra Hospital 1,700
Large-scale testing (Phase 3)Study completedNCT00139061
What this trial is testing

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Who this might be right for
Hyperlipidemia
Pfizer 128
Large-scale testing (Phase 3)Ended earlyNCT01294683
What this trial is testing

Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)

Who this might be right for
Primary HypercholesterolemiaDyslipidemia
Merck Sharp & Dohme LLC 977
Large-scale testing (Phase 3)Study completedNCT07295418
What this trial is testing

SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemias
Shenzhen Salubris Pharmaceuticals Co., Ltd. 618
Not applicableUnknownNCT03274089
What this trial is testing

Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk

Who this might be right for
HypertensionHyperlipidemia; MixedDiabetes Mellitus
SingHealth Polyclinics 120
Large-scale testing (Phase 3)Study completedNCT00138762
What this trial is testing

Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Who this might be right for
Hyperlipidemia
Pfizer 3,800
Not applicableStudy completedNCT01245738
What this trial is testing

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Who this might be right for
DyslipidemiasHypercholesterolemiaHypertriglyceridemia+2 more
Merck Sharp & Dohme LLC 635
Testing effectiveness (Phase 2)Ended earlyNCT00325455
What this trial is testing

MK0859 Dose-Ranging Study (0859-003)

Who this might be right for
HypercholesterolemiaMixed Hyperlipemia
Merck Sharp & Dohme LLC 500
Large-scale testing (Phase 3)Study completedNCT00378833
What this trial is testing

Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 1,300
Testing effectiveness (Phase 2)Study completedNCT04516291
What this trial is testing

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Who this might be right for
DyslipidemiasHyperlipidemiasHyperlipoproteinemias
Pfizer 286
Large-scale testing (Phase 3)Study completedNCT00092573
What this trial is testing

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
Organon and Co 576
Testing effectiveness (Phase 2)Study completedNCT05256654
What this trial is testing

LY3561774 in Participants With Mixed Dyslipidemia

Who this might be right for
DyslipidemiasLipid Metabolism DisordersMetabolic Diseases+1 more
Eli Lilly and Company 205
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Not applicableEnded earlyNCT01228019
What this trial is testing

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,166
Early research (Phase 1)Looking for participantsNCT07491172
What this trial is testing

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Who this might be right for
CardiovascularMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG 90
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT07278830
What this trial is testing

A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hypercholesterolemia and Mixed Dyslipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 214
Post-approval studies (Phase 4)WithdrawnNCT02069106
What this trial is testing

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

Who this might be right for
Mixed Hyperlipoproteinemia
Nordic Pharma, USA
Large-scale testing (Phase 3)WithdrawnNCT02947334
What this trial is testing

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Who this might be right for
Primary Hyperlipidemia or Mixed Dyslipidemia
Pfizer
Next Page